MCM
WVE icon

MAI Capital Management’s Wave Life Sciences WVE Stock Holding History

MAI Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.72K Buy
1,341
+1,330
+12,091% +$17.3K ﹤0.01% 3194
2025
Q4 		$187 Buy
+11
New +$112 ﹤0.01% 4064

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

MAI Capital Management's WVE Position: Q1 2026 in Review

MAI Capital Management increased its Wave Life Sciences (WVE) stake by 12,091% in Q1 2026, buying an estimated $17.3K and bringing the position to 1,341 shares worth $9.72K. The position accounts for ﹤0.01% of the portfolio, ranked #3194.

MAI Capital Management first reported a position in WVE in Q4 2025 and has held it in 2 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • MAI Capital Management held 1,341 shares of Wave Life Sciences worth $9.72K as of Q1 2026.
  • MAI Capital Management bought 1,330 Wave Life Sciences shares in Q1 2026, an estimated $17.3K.
  • Wave Life Sciences made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3194 holding.
  • MAI Capital Management first reported a position in Wave Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.